MEKINIST vs ZORTRESS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. MEKINIST and ZORTRESS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MEKINIST	ZORTRESS
Rating	70/100	70/100
Pharmacy pays	—	~$229.16 /30
Type	RX	RX
Active ingredient	TRAMETINIB DIMETHYL SULFOXIDE	EVEROLIMUS
Manufacturer	Novartis	Novartis
Dosage forms	Powder, Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Half-life	—	about 30 hours (mean terminal elimination half-life)
Treats	Non-Small-Cell Lung Carcinoma, Melanoma	—

mekinist zortress

Rating

70/100

Pharmacy pays

—

~$229.16 /30

Type

Active ingredient

TRAMETINIB DIMETHYL SULFOXIDE

EVEROLIMUS

Manufacturer

Novartis

Dosage forms

Powder, Tablet

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Half-life

—

about 30 hours (mean terminal elimination half-life)

Treats

Non-Small-Cell Lung Carcinoma, Melanoma

—

Frequently asked questions

Which is better-rated, Mekinist or Zortress?

Mekinist and Zortress are tied at 3.5 out of 5 by our independent rating.

What is the difference between Mekinist and Zortress?

Mekinist contains Trametinib Dimethyl Sulfoxide, while Zortress contains Everolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.